LABCORP HOLDINGS INC. Income (Loss) from Continuing Operations, Per Diluted Share
LABCORP HOLDINGS INC. (LH) reported Income (Loss) from Continuing Operations, Per Diluted Share of $10.46 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2026-02-24
- LABCORP HOLDINGS INC. income (loss) from continuing operations, per diluted share for the quarter ending 2025-03-31 was $2.52, a 6.32% decline year-over-year.
- LABCORP HOLDINGS INC. income (loss) from continuing operations, per diluted share for the quarter ending 2024-09-30 was $2.00, a 5.21% decline year-over-year.
- LABCORP HOLDINGS INC. income (loss) from continuing operations, per diluted share for the quarter ending 2024-06-30 was $2.43, a 39.66% increase year-over-year.
- LABCORP HOLDINGS INC. income (loss) from continuing operations, per diluted share for the quarter ending 2024-03-31 was $2.69, a 14.96% increase year-over-year.
- LABCORP HOLDINGS INC. income (loss) from continuing operations, per diluted share for fiscal 2025 was $10.46, a 18.33% increase from fiscal 2024.
- LABCORP HOLDINGS INC. income (loss) from continuing operations, per diluted share for fiscal 2024 was $8.84, a 104.16% increase from fiscal 2023.
- LABCORP HOLDINGS INC. income (loss) from continuing operations, per diluted share for fiscal 2023 was $4.33, a 60.42% decline from fiscal 2022.
- LABCORP HOLDINGS INC. income (loss) from continuing operations, per diluted share for fiscal 2022 was $10.94, a 51.42% decline from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|---|---|---|
| 2025-12-31 | $10.46 10-K · filed 2026-02-24 | |||
| 2025-03-31 | $2.52 10-Q · filed 2025-04-29 | |||
| 2024-12-31 | $8.84 10-K · filed 2026-02-24 | |||
| 2024-09-30 | $2.00 10-Q · filed 2024-10-29 | $7.13 10-Q · filed 2024-10-29 | ||
| 2024-06-30 | $2.43 10-Q · filed 2024-08-02 | $5.13 10-Q · filed 2024-08-02 | ||
| 2024-03-31 | $2.69 10-Q · filed 2025-04-29 | |||
| 2023-12-31 | $4.33 10-K · filed 2026-02-24 | |||
| 2023-09-30 | $2.11 10-Q · filed 2024-10-29 | $6.19 10-Q · filed 2024-10-29 | ||
| 2023-06-30 | $1.74 10-Q · filed 2024-08-02 | $4.08 10-Q · filed 2024-08-02 | ||
| 2023-03-31 | $2.34 10-Q · filed 2024-04-30 | |||
| 2022-12-31 | $10.94 10-K · filed 2025-02-25 | |||
| 2022-09-30 | $3.06 10-Q · filed 2023-10-30 | $10.45 10-Q · filed 2023-10-30 | ||
| 2022-06-30 | $2.89 10-Q · filed 2023-08-04 | $7.38 10-Q · filed 2023-08-04 | ||
| 2021-12-31 | $22.52 10-K · filed 2024-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |